Belvedere Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,218	Closed	-$131K	–	599
2023 Q1	$131K	Sell	1,218 -2,001	-62%	-$215K	﹤0.01%	101
2022 Q4	$354K	Buy	+3,219	New	+$354K	﹤0.01%	49